Tag: Audentes Therapeutics

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Audentes Therapeutics

Eventide Asset Management LLC Grows Stake in Audentes Therapeutics (BOLD)

Added to Collection on: 2018-06-25 20:07:05

Tags for this article:

Stock market
Stock
Corporate finance
Audentes Therapeutics

Click the tags to see associated articles and topics

View Article Details
Sofinnova Ventures Inc Invests $41.48 Million in Audentes Therapeutics (NASDAQ:BOLD) Stock

Added to Collection on: 2018-06-26 18:33:00

Tags for this article:

Money
Finance
Stock market
Stock
Financial economics
Equity securities
Share
Sofinnova
Audentes Therapeutics

Click the tags to see associated articles and topics

View Article Details
Redmile Group LLC Has $39.32 Million Stake in Audentes Therapeutics (BOLD)

Added to Collection on: 2018-06-27 19:58:03

Tags for this article:

Stock market
Stock
Corporate finance
Audentes Therapeutics

Click the tags to see associated articles and topics

View Article Details
HC Wainwright Reaffirms Buy Rating for La Jolla Pharmaceutical (NASDAQ:LJPC)

Added to Collection on: 2018-09-16 00:18:45

Tags for this article:

Health
Health care
Gene therapy
Cellectis
Coherus BioSciences
Editas Medicine
Companies
Audentes Therapeutics
Momenta Pharmaceuticals
Sangamo Therapeutics
Iovance Biotherapeutics
Atara Biotherapeutics
aUTOLUS THERAPEUTICS
DENALI THERAPEUTICS
Solid Biosciences
RUBIUS THERAPEUTICS

Click the tags to see associated articles and topics

View Article Details
Zacks: Brokerages Anticipate La Jolla Pharmaceutical (LJPC) Will Post Quarterly Sales of $3.38 ...

Added to Collection on: 2018-09-15 23:11:15

Tags for this article:

Health
Health care
Gene therapy
Cellectis
Coherus BioSciences
Editas Medicine
Companies
Audentes Therapeutics
Momenta Pharmaceuticals
Sangamo Therapeutics
Iovance Biotherapeutics
Atara Biotherapeutics
aUTOLUS THERAPEUTICS
DENALI THERAPEUTICS
Solid Biosciences
RUBIUS THERAPEUTICS

Click the tags to see associated articles and topics

View Article Details
Caribou Biosciences Appoints Jason O'Byrne as Chief Financial Officer

Added to Collection on: 2021-02-09 12:56:15

Tags for this article:

Branches of biology
Biology
Life Sciences
Rachel Haurwitz
Jennifer Doudna
Astellas Pharma
Gene therapy
Audentes Therapeutics
Caribou Biosciences Inc.

Click the tags to see associated articles and topics

View Article Details
Remix Therapeutics Appoints Matthew R. Patterson as Executive Chairman of its Board of Directors

Added to Collection on: 2021-03-16 10:52:30

Tags for this article:

Life Sciences
Branches of biology
Biology
Atlas Venture
BioMarin Pharmaceutical
Astellas Pharma
Gene therapy
Audentes Therapeutics
Remix Therapeutics

Click the tags to see associated articles and topics

View Article Details
Audentes CEO exits as Astellas rebrands a gene therapy buyout

Added to Collection on: 2021-04-01 13:43:27

Tags for this article:

Life Sciences
Biology
Branches of biology
Astellas Pharma
Mitsubishi UFJ Financial Group
Gene therapy
Novartis Gene Therapies
Novartis
Centronuclear myopathy
Sangamo Therapeutics
Audentes Therapeutics

Click the tags to see associated articles and topics

View Article Details
Third Harmonic, led by former Audentes CEO, launches with $155M in funding | BioPharma Dive

Added to Collection on: 2022-02-16 17:19:41

Tags for this article:

Life Sciences
Branches of biology
Biology
Astellas Pharma
Mitsubishi UFJ Financial Group
Gene therapy
Hives
Omalizumab
Audentes Therapeutics
Natalie Holles

Click the tags to see associated articles and topics

View Article Details
Astellas, despite recent setbacks, opens $100M gene therapy plant | BioPharma Dive

Added to Collection on: 2022-06-08 16:10:45

Tags for this article:

Life Sciences
Health sciences
Branches of biology
Astellas Pharma
Mitsubishi UFJ Financial Group
Biotechnology
Resamirigene bilparvovec
Antineoplastic drugs
Gene therapy
Seagen
Chemotherapy
Therapy
Audentes Therapeutics

Click the tags to see associated articles and topics

View Article Details